Literature DB >> 33477892

A Rare Coexistence of Paraneoplastic Cerebellar Degeneration: Papillary Thyroid Carcinoma.

Zeynep Özözen Ayas1, Gülgün Uncu1.   

Abstract

Paraneoplastic cerebellar degeneration (PCD) is a rare neuroimmunological disease that may accompany tumors. In this article, we present a patient with progressive gait difficulty who was diagnosed with PCD and, in a rare comorbidity, with papillary thyroid carcinoma (PTC) following malignancy screening. A 46-year-old male patient reported having experienced poor balance for 2 years. A neurological examination revealed nystagmus, intention tremor, and ataxia, and anti-thyroid peroxidase and anti-thyroglobulin levels were found to be elevated. A brain MRI showed significant cerebellar atrophy in the superior vermis. Malignancy screening for PCD was performed, and thyroid ultrasonography revealed a nodule in the left lobe, while PET/CT detected elevated focal F-18 fluorodeoxyglucose uptake in the thyroid. Onconeuronal antibodies (anti-Hu, anti-Yo, anti-Ri, anti-amphiphysin, anti-Tr, anti-PPCA-2, anti-Ma, anti-CV-1, and anti-ANNA-3) were negative. Pathologic examination of the thyroid revealed PTC, for which the patient was treated with 0.4 g/kg intravenous immunoglobulin and referred to the medical oncology department. This case demonstrates that clinicians must be alert to the rare comorbidity of PCD and PTC.

Entities:  

Keywords:  ataxia; papillary thyroid carcinoma; paraneoplastic cerebellar degeneration

Year:  2021        PMID: 33477892      PMCID: PMC7903265          DOI: 10.3390/curroncol28010055

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  14 in total

1.  [Paraneoplastic cerebellar degeneration and primary fallopian cancer].

Authors:  S Hezer; G Descargues; C Vignals; Y Imbert
Journal:  Gynecol Obstet Fertil Senol       Date:  2019-06-11

2.  Thyroid carcinoma detected by incidental (18)F-FDG uptake in a patient with progressive cerebellar syndrome.

Authors:  Alexander Kroiss; Christian Uprimny; Irene Johanna Virgolini
Journal:  Endocrine       Date:  2015-06-16       Impact factor: 3.633

Review 3.  Stroke-Like Presentation of Paraneoplastic Cerebellar Degeneration: a Single-Center Experience and Review of the Literature.

Authors:  Alberto Vogrig; Andrea Bernardini; Gian Luigi Gigli; Elisa Corazza; Alessandro Marini; Samantha Segatti; Martina Fabris; Jérôme Honnorat; Mariarosaria Valente
Journal:  Cerebellum       Date:  2019-10       Impact factor: 3.847

4.  Paraneoplastic cerebellar syndrome and sensory ganglionopathy with papillary thyroid carcinoma.

Authors:  James P Gratwicke; Adebayo Alli; Matthew Rollin; Francis Vaz; Jeremy Rees; Angela Vincent; Mark Edwards
Journal:  J Neurol Sci       Date:  2014-03-31       Impact factor: 3.181

5.  CTLA4 blockade elicits paraneoplastic neurological disease in a mouse model.

Authors:  Lidia M Yshii; Christina M Gebauer; Béatrice Pignolet; Emilie Mauré; Clémence Quériault; Mandy Pierau; Hiromitsu Saito; Noboru Suzuki; Monika Brunner-Weinzierl; Jan Bauer; Roland Liblau
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

6.  Long-term clinical outcome of paraneoplastic cerebellar degeneration and anti-Yo antibodies.

Authors:  I Rojas; F Graus; F Keime-Guibert; R Reñé; J Y Delattre; J M Ramón; J Dalmau; J B Posner
Journal:  Neurology       Date:  2000-09-12       Impact factor: 9.910

Review 7.  Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review.

Authors:  M Le May; S Dent
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

8.  Recommended diagnostic criteria for paraneoplastic neurological syndromes.

Authors:  F Graus; J Y Delattre; J C Antoine; J Dalmau; B Giometto; W Grisold; J Honnorat; P Sillevis Smitt; Ch Vedeler; J J G M Verschuuren; A Vincent; R Voltz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

Review 9.  Breast cancer and paraneoplastic cerebellar degeneration.

Authors:  D M Waterhouse; R B Natale; R L Cody
Journal:  Cancer       Date:  1991-10-15       Impact factor: 6.860

10.  [Renal cell carcinoma presenting as paraneoplastic neurological dysfunction].

Authors:  M J Hens; B Camacho; A Maestre; V González; I Villegas; M Magaña
Journal:  Actas Urol Esp       Date:  2008-06       Impact factor: 0.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.